Calculate your potential ROI with ACT

Tested in over 300 breast health clinics across the US, ACT has proven results across the board(1,2). Input your Total Annual Screenings to estimate the ROI ACT can have at your clinic.

Increase breast cancer screening compliance rates

Improve radiologists’ accuracy, productivity, and workflow

Optimize clinic operations to ensure patients receive timely and compassionate care

Total Annual Screenings

Estimated ROI

0
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
0

This calculation is based on a global average screening reimbursement of $205 and is for estimation purposes only. Actual results will vary.

Footnotes

1. Compared to a previous average of about 1% or less growth per year.
2. Average growth rate across all clinics using ACT.

Compliance Improvement Software

ACT is our AI-powered software solution designed to dramatically increase breast cancer screening compliance.

How It Works

Driving an average of 20% year-over-year growth in screening exam volumes in over 300 breast health clinics and growing across the US since launching in 2018.

ACT ingests and analyzes key demographic data points for each eligible patient¹ and automatically generates a targeted outreach strategy proven to motivate the individual to schedule their screening mammogram.

Agents trained on the ACT program are equipped with accurate, actionable information and our powerful algorithm-driven outreach strategy to increase mammography compliance.

Whiterabbit has helped RadNet to better mine our data, allowing us to significantly enhance patient compliance with screening mammography guidelines and to more accurately measure our screening capacity and expansion opportunities.  They have been a valued business partner in our efforts to create enhanced awareness of breast cancer screening and in growing our mammography volume.

Stephen M. Forthuber
President and Chief Operating Officer
Eastern Operations

Whiterabbit has helped RadNet to better mine our data, allowing us to significantly enhance patient compliance with screening mammography guidelines and to more accurately measure our screening capacity and expansion opportunities.  They have been a valued business partner in our efforts to create enhanced awareness of breast cancer screening and in growing our mammography volume.

Stephen M. Forthuber
President and Chief Operating Officer
Eastern Operations

Unique Features

Increase revenue. Increase patient compliance. Improve outcomes.

Our proprietary AI-powered software was trained on millions of data points, designed to motivate the user to action.

Intelligent from start to finish.



ACT’s robust data analytics provide a range of powerful insights to our clients about their mammography program.

Growth that scales.

ACT software dynamically scales to meet increasing volumes without requiring laborious 1:1 follow-ups.

Find out how our products can help your business increase compliance, increase revenue and improve outcomes.

Request A Demo
Footnotes

1 Eligible patient is defined as any woman who has a screening mammogram within the previous five years.

2 Moorman S, Pujara A, Sakala M, et al. Annual Screening Mammography Associated With Lower Stage Breast Cancer Compared With Biennial Screening. American Journal of Roentgenology 2021 217:1, 40-47